Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Sponsor: University of Wisconsin, Madison
Summary
The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be actively engaged in the study for up to 26 weeks.
Official title: Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample
Key Details
Gender
All
Age Range
25 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2023-03-03
Completion Date
2026-05
Last Updated
2025-12-18
Healthy Volunteers
No
Conditions
Interventions
Psilocybin
25mg orally followed by 25 mg or 50 mg orally
Locations (1)
University of Wisconsin
Madison, Wisconsin, United States